These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 9553129

  • 1. Identity of the residues responsible for the species-restricted complement inhibitory function of human CD59.
    Zhao XJ, Zhao J, Zhou Q, Sims PJ.
    J Biol Chem; 1998 Apr 24; 273(17):10665-71. PubMed ID: 9553129
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chimeras of human complement C9 reveal the site recognized by complement regulatory protein CD59.
    Hüsler T, Lockert DH, Kaufman KM, Sodetz JM, Sims PJ.
    J Biol Chem; 1995 Feb 24; 270(8):3483-6. PubMed ID: 7533152
    [Abstract] [Full Text] [Related]

  • 4. Role of a disulfide-bonded peptide loop within human complement C9 in the species-selectivity of complement inhibitor CD59.
    Husler T, Lockert DH, Sims PJ.
    Biochemistry; 1996 Mar 12; 35(10):3263-9. PubMed ID: 8605162
    [Abstract] [Full Text] [Related]

  • 5. Characterization of rabbit complement component C8. Functional evidence for the species-selective recognition of C8 alpha by homologous restriction factor (CD59).
    White RV, Kaufman KM, Letson CS, Platteborze PL, Sodetz JM.
    J Immunol; 1994 Mar 01; 152(5):2501-8. PubMed ID: 7510745
    [Abstract] [Full Text] [Related]

  • 6. Identification of mutations in rat CD59 that increase the complement regulatory activity.
    Hinchliffe SJ, Morgan BP.
    Biochemistry; 2000 May 16; 39(19):5831-7. PubMed ID: 10801333
    [Abstract] [Full Text] [Related]

  • 7. Mapping the regions of the complement inhibitor CD59 responsible for its species selective activity.
    Yu J, Dong S, Rushmere NK, Morgan BP, Abagyan R, Tomlinson S.
    Biochemistry; 1997 Aug 05; 36(31):9423-8. PubMed ID: 9235986
    [Abstract] [Full Text] [Related]

  • 8. Identification and functional characterization of a new gene encoding the mouse terminal complement inhibitor CD59.
    Qian YM, Qin X, Miwa T, Sun X, Halperin JA, Song WC.
    J Immunol; 2000 Sep 01; 165(5):2528-34. PubMed ID: 10946279
    [Abstract] [Full Text] [Related]

  • 9. Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity.
    Ninomiya H, Stewart BH, Rollins SA, Zhao J, Bothwell AL, Sims PJ.
    J Biol Chem; 1992 Apr 25; 267(12):8404-10. PubMed ID: 1373727
    [Abstract] [Full Text] [Related]

  • 10. Expression of recombinant CD59 with an N-terminal peptide epitope facilitates analysis of residues contributing to its complement-inhibitory function.
    Zhou Q, Zhao J, Hüsler T, Sims PJ.
    Mol Immunol; 1996 Oct 25; 33(14):1127-34. PubMed ID: 9047379
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA, Zhao J, Ninomiya H, Sims PJ.
    J Immunol; 1991 Apr 01; 146(7):2345-51. PubMed ID: 1706395
    [Abstract] [Full Text] [Related]

  • 12. Crystal structure of CD59: implications for molecular recognition of the complement proteins C8 and C9 in the membrane-attack complex.
    Huang Y, Fedarovich A, Tomlinson S, Davies C.
    Acta Crystallogr D Biol Crystallogr; 2007 Jun 01; 63(Pt 6):714-21. PubMed ID: 17505110
    [Abstract] [Full Text] [Related]

  • 13. Identification of the individual residues that determine human CD59 species selective activity.
    Zhang HF, Yu J, Chen S, Morgan BP, Abagyan R, Tomlinson S.
    J Biol Chem; 1999 Apr 16; 274(16):10969-74. PubMed ID: 10196177
    [Abstract] [Full Text] [Related]

  • 14. Binding of human and rat CD59 to the terminal complement complexes.
    Lehto T, Morgan BP, Meri S.
    Immunology; 1997 Jan 16; 90(1):121-8. PubMed ID: 9038722
    [Abstract] [Full Text] [Related]

  • 15. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
    Tomlinson S, Whitlow MB, Nussenzweig V.
    J Immunol; 1994 Feb 15; 152(4):1927-34. PubMed ID: 7509832
    [Abstract] [Full Text] [Related]

  • 16. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.
    Farkas I, Baranyi L, Ishikawa Y, Okada N, Bohata C, Budai D, Fukuda A, Imai M, Okada H.
    J Physiol; 2002 Mar 01; 539(Pt 2):537-45. PubMed ID: 11882685
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
    Ninomiya H, Sims PJ.
    J Biol Chem; 1992 Jul 05; 267(19):13675-80. PubMed ID: 1377690
    [Abstract] [Full Text] [Related]

  • 20. Mapping the active site of CD59.
    Yu J, Abagyan R, Dong S, Gilbert A, Nussenzweig V, Tomlinson S.
    J Exp Med; 1997 Feb 17; 185(4):745-53. PubMed ID: 9034152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.